Artrya Limited (AYA.AX)
Artrya Limited operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in West Perth, WA, AU. The stock last traded at $4.61, down 3.96% on the session, giving a market capitalisation of $751.3M. Its beta of 0.59 implies it has historically moved less than the broad market.
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Artrya Limited is most often compared with the following Healthcare names: